Merck & Co., Inc. (SNSE:MRK)

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of CLP 261.61 trillion. The enterprise value is 281.74 trillion.

Market Cap	261.61T
Enterprise Value	281.74T

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Dec 15, 2025

Share Statistics

Current Share Class	2.48B
Shares Outstanding	n/a
Shares Change (YoY)	-1.34%
Shares Change (QoQ)	-0.40%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.48B

Valuation Ratios

The trailing PE ratio is 15.91 and the forward PE ratio is 23.76.

PE Ratio	15.91
Forward PE	23.76
PS Ratio	4.47
PB Ratio	5.60
P/TBV Ratio	19.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	17.13
EV / Sales	5.00
EV / EBITDA	11.28
EV / EBIT	13.26
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.80
Debt / EBITDA	1.44
Debt / FCF	n/a
Interest Coverage	18.06

Financial Efficiency

Return on equity (ROE) is 37.17% and return on invested capital (ROIC) is 28.30%.

Return on Equity (ROE)	37.17%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	28.30%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	5.97%
Revenue Per Employee	791.35M
Profits Per Employee	222.20M
Employee Count	75,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Merck & Co. has paid 2.53 trillion in taxes.

Income Tax	2.53T
Effective Tax Rate	13.31%

Stock Price Statistics

The stock price has decreased by -8.46% in the last 52 weeks. The beta is 0.39, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	-8.46%
50-Day Moving Average	108.75
200-Day Moving Average	86.31
Relative Strength Index (RSI)	93.69
Average Volume (20 Days)	47

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.98

Income Statement

In the last 12 months, Merck & Co. had revenue of CLP 58.56 trillion and earned 16.44 trillion in profits. Earnings per share was 6,557.61.

Revenue	58.56T
Gross Profit	45.14T
Operating Income	22.07T
Pretax Income	18.98T
Net Income	16.44T
EBITDA	25.94T
EBIT	22.07T
Earnings Per Share (EPS)	6,557.61

Balance Sheet

The company has 16.41 trillion in cash and 37.27 trillion in debt, with a net cash position of -20,861.83 billion.

Cash & Cash Equivalents	16.41T
Total Debt	37.27T
Net Cash	-20,861.83B
Net Cash Per Share	n/a
Equity (Book Value)	46.76T
Book Value Per Share	18,776.99
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 77.08%, with operating and profit margins of 37.69% and 28.08%.

Gross Margin	77.08%
Operating Margin	37.69%
Pretax Margin	32.41%
Profit Margin	28.08%
EBITDA Margin	44.30%
EBIT Margin	37.69%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 3,050.72, which amounts to a dividend yield of 2,587.55%.

Dividend Per Share	3,050.72
Dividend Yield	2,587.55%
Dividend Growth (YoY)	2.90%
Years of Dividend Growth	8
Payout Ratio	n/a
Buyback Yield	1.34%
Shareholder Yield	2,588.89%
Earnings Yield	6.29%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1